Valore20212022202320242025TTMSpese di vendita, generali e amministrative——————Ricerca e sviluppo——————Reddito operativo——————Proventi non operativi, Totale——————Oneri finanziari, al netto degli interessi capitalizzati——————Proventi non operativi, esclusi gli oneri finanziari——————Entrate/uscite straordinarie——————Utile al lordo delle imposte——————Quota di utile——————Imposte——————Interessi di minoranza——————Altri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate——————Attività cessate——————Utile netto——————Regolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari——————Utile base per azione (EPS base)——————Utile diluito per azione (EPS diluito)——————Numero medio di azioni ordinarie in circolazione——————Azioni diluite in circolazione——————EBITDA——————EBIT——————Costo del fatturato——————Altri costi del venduto——————Ammortamento e svalutazione (liquidità)——————
Novo Nordisk A/S
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices.
Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark.